Young age and pathological features predict breast cancer outcome - Report from a dual Institution experience in Serbia

Journal of B.U.ON.

Volumn 20, Issue 6, 2015, Pages 1407-1413

  Cvetanovic, Ana ^a   Popovic, Lazar ^b,c   Filipovic, Sladjana ^a,d   Trifunovic, Jasna ^b,c   Zivkovic, Nikola ^d,e   Matovina Brko, Gorana ^b,c   Kostic, Milos ^d   Vicko, Ferenc ^b,c   Kocic, Biljana ^d,f   Kolarov Bjelobrk, Ivana ^b,c  

^a University Hospital Nis   (Serbia)

^b ONCOLOGY INSTITUTE OF VOJVODINA   (Serbia)

^c UNIVERSITY OF NOVI SAD   (Serbia)

^d UNIVERSITY OF NI   (Serbia)

^e University Hospital   (Serbia)

^f Institute for Public Health of Nis   (Serbia)

Author keywords

35 years old; Breast cancer; Serbia; Young age

Indexed keywords

ANTHRACYCLINE; AROMATASE INHIBITOR; CYCLOPHOSPHAMIDE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FLUOROURACIL; GONADORELIN DERIVATIVE; METHOTREXATE; TAMOXIFEN; TAXANE DERIVATIVE; TRASTUZUMAB;

ADULT; AGE; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HISTOPATHOLOGY; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; LYMPH NODE; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SERBIA; TUMOR VOLUME; UNIVARIATE ANALYSIS; UNIVERSITY HOSPITAL; BREAST TUMOR; MORTALITY; PATHOLOGY;

ADULT; AGE FACTORS; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; NEOPLASM STAGING;

EID: 84960130408     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Atanasković-Marković Z, Bjegović V, Janković S et al. The Burden of Disease and Injury in Serbia. Belgrade (Serbia): Ministry of Health of the Republic of Serbia; 2003.
2. El Saghir N.S., Seoud M, Khalil MK et al. Effects of young age at presentation on survival in breast cancer. BMC Cancer 2006; 6:194.
3. Bharat A, Aft RL, Gao F, Margenthaler JA Patient and tumor characteristics associated with increased mortality in young women (< or= 40 years) with breast cancer. J Surg Oncol 2009; 100:248-251.
4. Holli K, Isola J. Effect of age on the survival of breast cancer patients. Eur J Cancer 1997; 33:425-428.
5. Kollias J, Elston CW, Ellis I.O., Robertson JF, Blarney RW Early-onset breast cancer-histopathological and prognos-tic considerations. Br J Cancer 1997; 75:1318-1323.
6. Kim EK, Noh WC, Han W, Noh DY Prognostic significance of young age (<35 years) by subtype based on ER, PR, and HER2 status in breast cancer: a nationwide registry-based study. World J Surg 2011; 35:1244-1253.
7. Han W, Kang SY The Korean Breast Cancer Society. Relationship between age at diagnosis and outcome of premenopausal breast cancer age less than 35 years is a reasonable cut-off for defining young age-onset breast cancer. Breast Cancer Res Treat 2010; 119:193-200.
8. Love RR, Duc NB, Baumann LC et al. Duration of signs and survival in premenopausal women with breast cancer. Breast Cancer Res Treat 2004; 86:117-124.
9. Lakhani SR, Ellis IO, Schnitt S.J., Tan PH, van de Vijver MJ. WHO classification of tumours of the breast (4th Edn). IARC Press, Lyon, 2012.
10. Elston CW, Ellis IO Pathological prognostic factors in breast cancer. The value of histological grade in breast cancer: experience from large study with long-term follow up. Histopathology 1991; 19:403-410.
11. Allred DC, Harvey JM, Berardo M, Clark GM Prognostic and predictive factors in breast cancer by immunohisto-chemical analysis. Mod Pathol 1998; 11:155-168.
12. Breast In: Edge SB, Byrd DR, Compton CC et al. (Eds): AJCC Cancer Staging Manual (7th Edn). New York, Springer, 2010, pp 347-376.
13. Han W, Kim SW, Park IA et al. Young age: an independent risk factor for disease-free survival in women with operable breast cancer. BMC Cancer 2004; 4:82.
14. Figueiredo JC, Ennis M, Knight JA et al. Influence of young age at diagnosis and family history of breast or ovarian cancer on breast cancer outcomes in a population-based cohort study. Breast Cancer Res Treat 2007; 105:69-80.
15. Gajdos C, Tartter PI, Bleiweiss I.J., Bodian C., Brower ST Stage 0 to stage III breast cancer in young women. J Am Coll Surg 2000; 190:523-529.
16. Anders CK, Fan C, Parker JS et al. Breast carcinomas arising at a young age: unique biology or a surrogate for aggressive intrinsic subtypes? J Clin Oncol 2011; 29:e18-20.
17. Kroman N, Jensen MB, Wohlfahrt J, Mouridsen H., Andersen PK, Melbye M. Factors influencing the effect of age on prognosis in breast cancer: population based study. BMJ 2000; 320:474-478.
18. Azim HA J.r., Michiels S, Bedard PL et al. Elucidating prognosis and biology of breast cancer arising in young women using gene expression profiling. Clin Cancer Res 2012; 18:1341-1351.
19. Chia KS, Du WB, Sankarana Rayanan R et al. Do younger female breast cancer patients have a poorer prognosis? Results from a population-based survival analysis. Int J Cancer 2004; 108:761-765.
20. Rapiti E, Fioretta G, Verkooijen HM et al. Survival of young and older breast cancer patients in Geneva from 1990 to 2001. Eur J Cancer 2005; 41:1446-1452.
21. Winchester DP, Osteen RT, Menck HR The National Cancer Data Base report on breast carcinoma characteris-tics and outcome in relation to age. Cancer 1996; 78:1838-1843.
22. Sorlie T, Perou CM, Tibshirani R et al. Gene expression patterns of breast carcinomas distinguish tumor sub-classes with clinical implications. Proc Natl Acad Sci U S A 2001; 98:10869-10874.
23. Sotiriou C, Neo SY, McShane LM et al. Breast cancer classification and prognosis based on gene expression pro-files from a population-based study. Proc Natl Acad Sci USA 2003; 100:10393-10398.
24. Collins LC, Marotti JD, Gelber S et al. Pathologie features and molecular phenotype by patient age in a large cohort of young women with breast cancer. Breast Cancer Res Treat 2012; 131:1061-1066.
25. Tang LC, Yin WJ, Di G.H., Shen ZZ, Shao ZM Unfavourable clinicopathologic features and low response rate to systemic adjuvant therapy: results with regard to poor survival in young Chinese breast cancer patients. Breast Cancer Res Treat 2010; 122:95-104.
26. Maishman T, Copson E, Stanton L et al. An evaluation of the prognostic model PREDICT using the POSH cohort of women aged s 40 years at breast cancer diagnosis. Br J Cancer 2015; 112:983-991.
27. Cancello G, Maisonneuve P, Mazza M et al. Pathological features and survival outcomes of very young patients with early breast cancer: How much is "very young"?. The Breast 2013; 22:1046-1051.
28. De la Rochefordiere A, Asselain B, Campana F et al. Age as prognostic factor in premenopausal breast carcinoma. Lancet 1993; 341:39-43.